14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Diabetes Mellitus, Type 2 in 2 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, J | 1 |
| Zhao, Y | 1 |
| Fan, Z | 1 |
| Chen, Q | 1 |
| Chen, J | 1 |
| Sun, Y | 1 |
| Jiang, X | 1 |
| Xiao, Q | 1 |
| Zhu, QF | 1 |
| Hao, YH | 1 |
| Liu, MZ | 1 |
| Yue, J | 1 |
| Ni, J | 1 |
| Yuan, BF | 1 |
| Feng, YQ | 1 |
2 other studies available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Soluble epoxide hydrolase inhibitor protects against blood-brain barrier dysfunction in a mouse model of type 2 diabetes via the AMPK/HO-1 pathway.
Topics: 8,11,14-Eicosatrienoic Acid; AMP-Activated Protein Kinases; Animals; Blood-Brain Barrier; Diabetes M | 2020 |
Analysis of cytochrome P450 metabolites of arachidonic acid by stable isotope probe labeling coupled with ultra high-performance liquid chromatography/mass spectrometry.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acid; Brain; Case-Control Studies; Chromatography, | 2015 |